Gilead Sciences | Driftskostnader

Operating Expenses Endring Dato
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Gilead Sciences Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.